| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.26 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |